 Shares of 10x Genomics Inc. TXG, -7.74 fell in the extended session Thursday after the biotech company said it expects second-quarter revenue to come in below Wall Street expectations. 10x Genomics shares dropped 15 after hours, following a 7.7 drop in the regular session to close at 43.29. 